Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BioBrit

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 8
Rounds per year 0.92
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.27
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Health Diagnostics
  • Medical
Summary

BioBrit appeared to be the Corporate Investor, which was created in 2012.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the BioBrit, startups are often financed by Silicon Valley Bank, Sears Capital Management, Oxford Finance LLC. The meaningful sponsors for the fund in investment in the same round are Sears Capital Management, NEXT Frontier Capital, Mission Bay Capital. In the next rounds fund is usually obtained by Sears Capital Management, NEXT Frontier Capital, Mission Bay Capital.

Among the most popular fund investment industries, there are Therapeutics, Medical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight SiteOne Therapeutics, Castle Biosciences.

The increased amount of exits for fund were in 2019. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2018. This BioBrit works on 4 percentage points less the average amount of lead investments comparing to the other organizations.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BioBrit:
Typical Co-investors
BioBrit is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BioBrit:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Cognitive Investment -
Copper Wire Ventures -
ETCapital Cambridge, Cambridgeshire, United Kingdom
Fuji Xerox Auckland, Auckland, New Zealand
Gaspar Global Ventures New York, New York, United States
IR Robotics Chiyoda, Japan
Porto Seguro Brazil, São Paulo, Sao Paulo
Shenzhen Runiu Touzi China, Guangdong, Shenzhen
Yuandian Maoyi China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Creyon Bio

Biotechnology
Life Science
$40M08 Mar 2022 San Diego, California, United States

Amplo Biotechnology

Biotechnology
Health Care
Neuroscience
Therapeutics
06 Oct 2021 Pompano Beach, Florida, United States

Stuart Therapeutics

Biotechnology
Health Care
Therapeutics
$11M19 Mar 2021 Florida, United States

Primmune Therapeutics

Biotechnology
Health Care
$27M27 Oct 2020 San Diego, California, United States

Primmune Therapeutics

Biotechnology
Health Care
$7M02 Mar 2020 San Diego, California, United States

Compass Therapeutics

Biopharma
Biotechnology
Therapeutics
11 Jul 2017 Boston, Massachusetts, United States

SiteOne Therapeutics

Biotechnology
Health Diagnostics
Medical
Therapeutics
$15M06 Jan 2017 Bozeman, Montana, United States

SiteOne Therapeutics

Biotechnology
Health Diagnostics
Medical
Therapeutics
$1M24 Sep 2014 Bozeman, Montana, United States
News
Stuart Therapeutics Raises $11M in Series A Funding

– Stuart Therapeutics from Stuart, Florida develops peptide therapeutics for ophthalmic diseases.
– The company raised $11m in Series A funding.
– The round was led by InFocus Capital Partners, with participation from the Wisconsin Alumni Research Foundation (WARF), MiMo Capital and BioBrit.
– The proceeds from the round will fund Phase 2 clinical trials for the company’s proprietary reparative therapeutic candidate, ST-100.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioBrit?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 11
Average round size 9M
Rounds per year 0.92
Peak activity year 2021
Lead investments 2
Follow on index 0.27
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Creyon Bio

Biotechnology
Life Science
$40M08 Mar 2022 San Diego, California, United States

Amplo Biotechnology

Biotechnology
Health Care
Neuroscience
Therapeutics
06 Oct 2021 Pompano Beach, Florida, United States

Stuart Therapeutics

Biotechnology
Health Care
Therapeutics
$11M19 Mar 2021 Florida, United States

Primmune Therapeutics

Biotechnology
Health Care
$27M27 Oct 2020 San Diego, California, United States

Primmune Therapeutics

Biotechnology
Health Care
$7M02 Mar 2020 San Diego, California, United States

Compass Therapeutics

Biopharma
Biotechnology
Therapeutics
11 Jul 2017 Boston, Massachusetts, United States

SiteOne Therapeutics

Biotechnology
Health Diagnostics
Medical
Therapeutics
$15M06 Jan 2017 Bozeman, Montana, United States

SiteOne Therapeutics

Biotechnology
Health Diagnostics
Medical
Therapeutics
$1M24 Sep 2014 Bozeman, Montana, United States
Crunchbase icon

Content report

The following text will be sent to our editors: